You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The University of Toronto's Mikko Taipale is working on developing new technologies to pave the way for gaining new biological insights.
Technion's Reut Shalgi is building up her lab to study how chaperones affect protein synthesis and protein folding.
EMBL-EBI's Oliver Stegle is taking a statistical approach to understanding genotype-phenotype associations.
Harvard Medical School's Kaitlin Samocha is studying de novo mutations linked to complex diseases like autism and schizophrenia.
Pacific Northwest National Laboratory's Sangtae Kim is taking on the challenges of analyzing top-down proteomic data.
At Brigham and Women's Hospital, Kimberly Glass is integrating different types of omics data to develop useful gene models.
Duke University's Slavé Petrovski is working to elucidate which genetic variations are likely benign versus ones that may be linked to disease.
By modeling organisms with systems biology data, Mount Sinai School of Medicine's Jonathan Karr plans to eventually engineer bacteria.
The Genome Institute of Singapore's Yue Wan is interested in why RNA folds as it does.
Sick Kids' Mohammed Uddin is analyzing various types of gene expression and mutational data to better understand autism.
The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.
The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.
Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.
In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.